Impact of an Integrated Obesity Management System on Patient's Care (ROGMF-2)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
Marie-France Langlois, Université de Sherbrooke
ClinicalTrials.gov Identifier:
NCT00991640
First received: October 7, 2009
Last updated: March 3, 2014
Last verified: March 2014

October 7, 2009
March 3, 2014
November 2009
December 2013   (final data collection date for primary outcome measure)
  • Among patients from the targeted diseases group, we aim at improving: a)the proportion of subjects who have an initial intervention planned, according to the CCPGO; b)the proportion of subjects who lose at least 5% of their initial weight. [ Time Frame: 18 months ] [ Designated as safety issue: No ]
  • Among patients from the regular follow-up group, we aim at improving: a)the proportion of patients who have measured weight, BMI and waist circumference and b)the proportion of overweight or obese subjects who have an initial intervention planned. [ Time Frame: 18 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00991640 on ClinicalTrials.gov Archive Site
  • Among health professionals who receive the intervention (vs. those who did not), we aim at ameliorating their attitudes and perceptions towards patients and treatment effectiveness. [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • Among health professionals who receive the intervention (vs. those who did not), we aim at improving their perception of self-efficacy in managing obesity. [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • Among health professionals who receive the intervention (vs. those who did not), we aim at increasing their knowledge and expertise on obesity management and changing their practice. [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • Among patients who are followed by PCPs who receive the intervention (vs. no intervention), we aim at:a) evaluating their attitudes and perceptions regarding obesity/overweight and lifestyle and b)improving their satisfaction regarding their management. [ Time Frame: 18 months ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Impact of an Integrated Obesity Management System on Patient's Care
Impact of an Integrated Obesity Management System on Patient's Care

The investigators developed a program aimed at enhancing primary care physician (PCP) teams' expertise, self-efficacy and attitudes with respect to obesity management. The investigators implemented and evaluated this obesity management system based on a preceptorship combined with a virtual learning community favouring continuous support of family medicine groups (FMGs, Groupes de Médecine Familiale) by a team of experts in obesity management; significant improvements regarding their attitudes and perception of self-efficacy were observed immediately after the preceptorship and maintained after one year. Furthermore, the investigators observed significant changes in their practice that were maintained one year later.

The investigators hypothesize that their program combining preceptorships with a virtual community will improve: (1) management and weight loss of obese/overweight subjects who are treated by PCPs for hypertension (HTN), type 2 diabetes (DM2) or impaired glucose tolerance (IGT); and (2) screening and initial management of obesity among unselected patients of PCPs who practice in FMGs.

Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Health Services Research
Obesity
Behavioral: 2-day preceptorship on obesity management
  • No Intervention: Control
    No intervention
  • Experimental: Preceptorships
    Preceptorships with e-learning
    Intervention: Behavioral: 2-day preceptorship on obesity management
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
460
June 2014
December 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients who have, during the past 2 years, at least 4 documented visits for the targeted diseases group and at least 2 visits for the regular follow-up group

Exclusion Criteria:

  • Active mental health problem
  • Active psychiatric disorder
  • Cancer in the last five years
  • Patient with medication that changed in the last 6 months
Both
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
Canada
 
NCT00991640
09-022
No
Marie-France Langlois, Université de Sherbrooke
Université de Sherbrooke
Canadian Institutes of Health Research (CIHR)
Not Provided
Université de Sherbrooke
March 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP